Crescent Biopharma Inc (CBIO) PT Lowered to $22 at H.C. Wainwright Mar 2, 2026 07:13AM
Crescent Biopharma Inc (CBIO) PT Lowered to $29 at Stifel Feb 26, 2026 03:52PM
Piper Sandler Starts Crescent Biopharma Inc (CBIO) at Overweight Jan 28, 2026 04:31AM
Guggenheim Starts Crescent Biopharma Inc (CBIO) at Buy Jan 21, 2026 06:10AM
Crescent Biopharma receives regulatory clearances for two cancer drugs Jan 5, 2026 07:00AM


Dec 4, 2025 04:18PM Crescent Biopharma Inc (CBIO) PT Raised to $32 at Stifel
Nov 6, 2025 04:29PM Catalyst Biosciences (CBIO) Misses Q3 EPS by 127c
Aug 27, 2025 08:28AM Stifel Reiterates Buy Rating on Crescent Biopharma Inc (CBIO)
Aug 25, 2025 12:23AM Jefferies Starts Crescent Biopharma Inc (CBIO) at Buy
Aug 11, 2025 06:36AM H.C. Wainwright Starts Catalyst Biosciences (CBIO) at Buy
Jul 14, 2025 06:54AM Wedbush Starts Catalyst Biosciences (CBIO) at Outperform
Jul 8, 2025 07:30AM Crescent Biopharma names Jan Pinkas as chief scientific officer
Jun 24, 2025 04:06PM Stifel Starts Catalyst Biosciences (CBIO) at Buy